MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Vertigo: Sway pattern indicating a functional movement disorder

    L. Schappe, N. Rohmann, F. Röll, D. Martens, A. Păniță, J. Stögbauer, G. Wagenpfeil, K. Faßbender, U. Dillmann (Homburg, Germany)

    Objective: To estimate the value of static posturography (PUG) to detect functional postural instability in patients with acute vertigo syndromes in an emergency department Background:…
  • 2023 International Congress

    Autoimmune Chorea. Therapy with Monoclonal Antibodies: Experimental and Clinical Approach

    D. Labunskiy, S. Kiryukhina, D. Kuzmin, V. Podsevatkin (Saransk, Russian Federation)

    Objective: Autoimmune chorea (AICh) resulting from the appearance of paraneoplastic antibodies in response to development of malignant tumors of various localization. Sydenham's rheumatic chorea, described…
  • 2023 International Congress

    atrophy of cranial nerves v and viii is a hallmark of rfc1-related disorder

    C. Lobo, G. Wertheimer, T. Rezende, PC. Matos, L. Branco, J. Silva, F. Borba, O. Barsottini, JL. Pedroso, W. Marques Jr, M. França Jr (Campinas, Brazil)

    Objective: To assess the usefulness of cranial nerves V (CNV) and VIII (CNVIII) atrophy as a neuroradiological sign to differentiate RFC1-related disorder from spinocerebellar ataxias…
  • 2023 International Congress

    Conventional anti-epileptic drugs used in North Sea Progressive Myoclonus Epilepsy revisited in a Drosophila model

    S. Polet, R. Lambrechts, M. de Koning-Tijssen, O. Sibon, T. de Koning, J. Gorter (Groningen, Netherlands)

    Objective: To determine the effect of conventional anti-epileptic drugs in a North Sea Progressive Myoclonus Epilepsy (NS-PME) Drosophila model. Background: In 2011, Corbett et al.…
  • 2023 International Congress

    Drivers of Health-Related Quality of Life in Parkinson’s Disease: non-motor symptoms and time spent in daily activities

    C. Painous, I. Pijuan, E. Tolosa (Barcelona, Catalonia)

    Objective: The purpose of this study was to identify factors associated with health-related quality of life (HRQoL) in people with Parkinson’s Disease (PwP). Background: HRQoL…
  • 2023 International Congress

    The impact on religiosity following Deep Brain Stimulation (DBS) in patients with Essential Tremor (ET) and Parkinson’s Disease (PD)

    J. Frey, J. Lobo Lopes, M. Wajid, L. Kugler, C. Hess (Morgantown, USA)

    Objective: To determine the impact of DBS on religiosity. Background: Religiosity has been mapped to various brain networks1, 2, and transcranial magnetic stimulation has transiently…
  • 2023 International Congress

    Dystonia Treatment With Injections Supplemented by TMS: the D-TWIST Study

    J. Frey, J. Yu, J. Lobo Lopes, L. Fanty, I. Malaty, A. Ramirez-Zamora, M. Wajid, J. Cagle, C. de Hemptinne, A. Wagle Shukla (Morgantown, USA)

    Objective: To evaluate the safety, feasibility, tolerability and effects of accelerated rTMS for treatment of cervical dystonia. Background: In a subgroup of patients with cervical…
  • 2023 International Congress

    Traveling through the telescope: a neuromuscular and a movement disorders reunion

    A. Fernandes, M. Pinto, C. Soares, L. Braz, M. Rosas (PESO DA RÉGUA, Portugal)

    Objective: We aim to raise awareness to an uncommon but possible combination of Parkinson Disease (PD) and Myasthenia Gravis (MG). Background: The co-occurrence of PD…
  • 2023 International Congress

    Cerebral Topography of [11C]-Flumazenil GABAA Receptor Expression in Parkinson’s Disease Fallers and Freezers

    N. Bohnen, S. Roytman, J. Barr, K. Frey, P. Scott, R. Koeppe, P. Kanel (Ann Arbor, USA)

    Objective: To examine the cerebral topography of GABAA Receptor Expression in Parkinson’s Disease (PD) Fallers and Freezers. Background: Episodic mobility disturbances, like falls and freezing…
  • 2023 International Congress

    Expanding the spectrum of Hereditary Spastic Paraplegia: An interesting Case .

    D. Joshi, S. Pattanayak, S. Parida, A. Kumar (Varanasi, India)

    Objective: We describe an interesting case of a young adult with a 5 year progressive history of spastic quadripareisis , cognitive decline, seizures and pseudobulbar…
  • « Previous Page
  • 1
  • …
  • 156
  • 157
  • 158
  • 159
  • 160
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley